Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Today, relugolix has been approved for use by the NHS for people living with endometriosis. While it's been praised for its fast action and simple use, campaigners have warned it's by no means a ...

Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

We believe quality journalism should be available to everyone, paid for by those who can afford it. A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people ...

Hoorah for some positive women's health news! A new endometriosis pill has been made available on the NHS in England, in what ...

A transformational new pill for treating endometriosis has been approved for use on the NHS across England. The new tablet, ...

Endometriosis affects approximately 1.5 million women in the UK, leading to chronic pain and fatigue as tissue similar to the ...

The new drug, called relugolix-estradiol-norethisterone, is a combination pill that blocks specific hormones that contribute to endometriosis, while also providing necessary hormone replacement ...

The drug that has been approved by the National Institute for Health and Care Excellence (Nice) is called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo).

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

The new pill is the first long-term daily pill licensed to treat the condition, and works by blocking specific hormones that contribute to endometriosis ...